Atlas Trials

A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Clinical trial NCT02418325 · TERMINATED

Trial details

NCT number
NCT02418325
Sponsor
Genesis Limited
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis, Relapsing-Remitting
Start date
2015-02-01
Primary completion
2017-02-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.